Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels
Ankit Dhiman, Charles C. Vining, Hunter D.D. Witmer, Divya Sood, Ardaman Shergill, Hedy Kindler, Kevin K. Roggin, Mitchell C. Posner, Osmanuddin S. Ahmed, Stanley Liauw, Sean Pitroda, Chih Yi Liao, Theodore Karrison, Ralph Weichselbaum, Blase Polite, Oliver S. Eng, Daniel V.T. Catenacci, Kiran K. Turaga
Dive into the research topics of 'Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels'. Together they form a unique fingerprint.